Kuehne+Nagel has opened a temperature-controlled airfreight cross dock pharma facility in Hyderabad, India. The city is a major centre for pharmaceutical manufacturing, contributing over 40% of India’s active pharma ingredients and vaccine production. The 248sq m facility operates across dedicated temperature zones, including +2°C to +8°C and +15°C to +25°C and complies with Kuehne+Nagel’s global HealthChain quality standard. The fowarder now operates two HealthChain-certified facilities in India, following the launch of its Bengaluru Cool Zone facility in December 2025.
